Armistice Capital LLC Acquires 20,073 Shares of Intuitive Surgical, Inc. $ISRG

Armistice Capital LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 61,073 shares of the medical equipment provider’s stock after buying an additional 20,073 shares during the quarter. Armistice Capital LLC’s holdings in Intuitive Surgical were worth $34,589,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Newbridge Financial Services Group Inc. raised its position in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the period. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Olistico Wealth LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Laurel Wealth Advisors LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $31,000. Finally, Turning Point Benefit Group Inc. raised its position in shares of Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ISRG. Leerink Partners lowered their price target on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. TD Cowen lowered their price target on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler reissued an “overweight” rating and issued a $580.00 price target on shares of Intuitive Surgical in a research report on Tuesday, June 2nd. Raymond James Financial lowered their price target on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $573.42.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 119 shares of the company’s stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the sale, the director owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 7,169 shares of company stock valued at $3,059,135. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Down 3.6%

Intuitive Surgical stock opened at $402.18 on Thursday. The firm’s 50 day simple moving average is $440.46 and its 200 day simple moving average is $492.22. The firm has a market capitalization of $142.44 billion, a PE ratio of 48.75, a price-to-earnings-growth ratio of 3.39 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $396.68 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical’s revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.81 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.